1997 Canadian research award for specialty residents in the division of surgery

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS22
Academic Journal
Presents an abstract of the research manuscript `Overexpression of the growth hormone-releasing hormone gene in acromegaly associated pituitary tumors: An event associated with neo-plastic progression and aggressive behavior,' by K. Thapar, K. Kovacs et al from the University of Toronto.


Related Articles

  • Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly. Penny, Elizabeth S.; Penman, Erica; Price, Janet; Rees, Lesley H.; Sopwith, A.M.; Wass, J.A.H.; Lytras, N.; Besser, G.M. // British Medical Journal (Clinical Research Edition);8/25/1984, Vol. 289 Issue 6443, p453 

    Examines the circulating growth hormone releasing factor (GRF) concentrations in patients with and without acromegaly in Great Britain. Measurement by radioimmunoassay; Evaluation of GRF concentrations in plasma samples;.

  • Ectopic acromegaly due to a GH-secreting pituitary adenoma in the sphenoid sinus: a case report and review of the literature. Ramírez, Claudia; Hernández-Ramirez, Laura-Cristina; Espinosa-de-los-Monteros, Ana-Laura; Franco, Juan Manuel; Guinto, Gerardo; Mercado, Moises // BMC Research Notes;2013, Vol. 6 Issue 1, p1 

    Background In more than 98% of cases, acromegaly is due to a GH-secreting pituitary adenoma. The term "ectopic acromegaly" includes neuroendocrine tumors secreting GH releasing hormone (GHRH), usually located in the lungs, thymus and endocrine pancreas. Considerably less frequent are cases of...

  • Regulation of 5′-Promoter Activity of the Rat Growth Hormone and Growth Hormone-Releasing Hormone Receptor Genes in the MtT/S and MtT/E Cells. Nogami, Haruo; Hiraoka, Yoshiki; Inoue, Kinji; Aiso, Sadakazu; Hisano, Setsuji // Neuroendocrinology;2006, Vol. 84 Issue 1, p31 

    The MtT/E and MtT/S cells have been established from a mammotrophic pituitary tumor, and postulated to be progenitor and premature growth hormone (GH) cells, respectively. The difference in the regulation of GH and GH-releasing hormone (GHRH) receptor gene transcription in relation to the...

  • Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Weckbecker, Gisbert; Lewis, Ian; Albert, Rainer; Schmid, Herbert A.; Hoyer, Daniel; Bruns, Christian // Nature Reviews Drug Discovery;Dec2003, Vol. 2 Issue 12, p999 

    Somatostatins - also known as somatotropin-release inhibiting factors (SRIFs) - are a family of cyclopeptides that have broad inhibitory effects on the secretion of hormones such as growth hormone, insulin and glucagon. These effects have formed the basis for the clinical use of SRIF analogues...

  • Ectopic Acromegaly Due to a Pancreatic Neuroendocrine Tumor Producing Growth Hormone-Releasing Hormone. Danielle Weiss; Hannes Vogel; M. Lopes; Steven Chang // Endocrine Practice;Jan2011, Vol. 17 Issue 1, p79 

    Objective: To present a case of acromegaly due to ectopic growth hormone-releasing hormone (GHRH) secretion from a pancreatic neuroendocrine tumor in the context of multiple endocrine neoplasia type 1 (MEN 1).Methods: We describe the clinical, imaging, and pathologic findings of the study...

  • Osteoarticular Changes in Acromegaly. Killinger, Zdenko; Kužma, Martin; Sterančáková, Lenka; Payer, Juraj // International Journal of Endocrinology;2012, p1 

    Acromegaly is caused by hypersecretion of growth hormone (GH) and consequently of insulin-like growth factor-I (IGF-1) due to pituitary tumor. Other causes, such as increased growth-hormone releasing hormone (GHRH) production, ectopic GHRH production, and ectopic GH secretion, are rare. Growth...

  • Acromegaly: Role of Surgery in the Therapeutic Armamentarium. Guinto, Gerardo; Abdo, Miguel; Zepeda, Erick; Arechiga, Norma; Mercado, Moisés // International Journal of Endocrinology;2012, p1 

    Acromegaly is a complex disease that requires the intervention of a multidisciplinary team. The most frequent clinical manifestations are growing of distal parts of the body and some areas of the face. Patients may also present arterial hypertension, diabetes mellitus, colonic polyps,...

  • Ectopic acromegaly due to growth hormone releasing hormone. Ghazi, Ali; Amirbaigloo, Alireza; Dezfooli, Azizollah; Saadat, Navid; Ghazi, Siavash; Pourafkari, Marina; Tirgari, Farrokh; Dhall, Dheepti; Bannykh, Serguei; Melmed, Shlomo; Cooper, Odelia // Endocrine (1355008X);Apr2013, Vol. 43 Issue 2, p293 

    Acromegaly secondary to extra-pituitary tumors secreting growth hormone releasing hormone (GHRH) is rarely encountered. We review the literature on ectopic acromegaly and present the index report of ectopic acromegaly secondary to GHRH secretion from a mediastinal paraganglioma. Clinical and...

  • Acromegaly. Chanson, Philippe; Salenave, Sylvie // Orphanet Journal of Rare Diseases;2008, Vol. 3, Special section p1 

    Acromegaly is an acquired disorder related to excessive production of growth hormone (GH) and characterized by progressive somatic disfigurement (mainly involving the face and extremities) and systemic manifestations. The prevalence is estimated at 1:140,000-250,000. It is most often diagnosed...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics